Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

• Kintampo Health Research Centre (GH)

tel qu’imprimé : Seth Owusu-Agyei

• Manhiça Health Research Centre (MZ)
• Eduardo Mondlane University (MZ)

• Ifakara Health Institute (TZ)
• Muhimbili University of Health and Allied Sciences (TZ)

• Institut de Recherche en Sciences de la Santé (BF)

• Ifakara Health Institute (TZ)
• Muhimbili University of Health and Allied Sciences (TZ)

• Institut de Recherche en Sciences de la Santé (BF)

• Institut de Recherche en Sciences de la Santé (BF)

• Ifakara Health Institute (TZ)
• Muhimbili University of Health and Allied Sciences (TZ)

tel qu’imprimé : Ali Takadir Mtoro

• Pwani University (KE)
• KEMRI-Wellcome Trust Research Programme (KE)
• Kenya Medical Research Institute (KE)

• Kenya Medical Research Institute (KE)

• Kenya Medical Research Institute (KE)

• Kenya Medical Research Institute (KE)

• National Institute for Medical Research (TZ)

tel qu’imprimé : Irving Hoffman

• Kintampo Health Research Centre (GH)

• Centre de Recherche Médicales de Lambaréné (GA)

tel qu’imprimé : Peter Kremsner

• Manhiça Health Research Centre (MZ)

• Centre de Recherche Médicales de Lambaréné (GA)

• National Institute for Medical Research (TZ)

• National Institute for Medical Research (TZ)

• Ministry of Health (MZ)
• Manhiça Health Research Centre (MZ)

• KEMRI-Wellcome Trust Research Programme (KE)
• Kenya Medical Research Institute (KE)

• Kwame Nkrumah University of Science and Technology (GH)

• Kintampo Health Research Centre (GH)

• KEMRI-Wellcome Trust Research Programme (KE)
• Kenya Medical Research Institute (KE)

tel qu’imprimé : James A Berkley

• Kwame Nkrumah University of Science and Technology (GH)

• Kwame Nkrumah University of Science and Technology (GH)

• Centre de Recherche Médicales de Lambaréné (GA)